| Literature DB >> 30673975 |
Alessandra F Perna1, Griet Glorieux2, Miriam Zacchia3, Francesco Trepiccione3, Giovanna Capolongo3, Carmela Vigorito3, Evgeniya Anishchenko3, Diego Ingrosso4.
Abstract
The gut microbiota is considered to be a novel important factor to take into account in the pathogenesis of chronic kidney disease and uremia. Much attention has been paid to specific uremic retention solutes of microbial origin, such as indoxyl sulfate, p-cresyl sulfate, and trimethylamine-N-oxide. However, other novel less well studied compounds, such as hydrogen sulfide and related sulfur metabolites (sulfane sulfur, lanthionine, etc.), should be included in a more comprehensive appraisal of this topic, in light of the potential therapeutic opportunities for the future.Entities:
Keywords: Chronic kidney disease; Dialysis; Homocysteine; Hydrogen sulfide; Lanthionine; Microbiota; Sulfane sulfur; Uremia; Uremic toxins
Year: 2019 PMID: 30673975 DOI: 10.1007/s40620-019-00589-z
Source DB: PubMed Journal: J Nephrol ISSN: 1121-8428 Impact factor: 3.902